Insto buying is based on one key metric:
THEIR Yearly BONUS
If IMUGENE looks likely to sign a deal in the very short term then they will pile in at any price for a quick profit. Until then the share price will drift. When the data drops and indicates effective cancer killing properties without toxic side effects at half the price of current SOC treatments then the likelihood of a deal increases and the share price will reflect that likelihood. With a sprinkling of luck dust we might even attract a larger player with gobble gobble tendencies.
Insto buying is based on one key metric:THEIR Yearly BONUS If...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.1¢ | 4.8¢ | $1.062M | 21.65M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 5138497 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 6291273 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |